Article
Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study.
Journal of the American Heart Association - 20 Apr 2021
Yuan Shuai, Burgess Stephen, Laffan Mike, Mason Amy M, Dichgans Martin, Gill Dipender, Larsson Susanna C
Abstract excerpt
Background We conducted Mendelian randomization analyses investigating the linear associations of genetically proxied inhibition of different coagulation factors with risk of common cardiovascular diseases. Methods and Results Genetic instruments proxying coagulation factor inhibition were identified from genome-wide association studies for activated partial thromboplastin time and prothrombin time in BioBank...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
